Strength
60 mg/mL
Manufacturer
Sandoz Inc.NDC
61314024063
Classification
Brand Biologic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
DENOSUMABApproval Type
Biologic (BLA)
FDA Application
BLA761362On Market Since
6/2/2025
Pharmacological Classes
RANK Ligand Blocking Activity
RANK Ligand Inhibitor
Related Drugs
Same classification
No related drugs found.